These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8178324)

  • 1. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.
    Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B
    Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
    Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
    Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An estimate of the number of human immunodeficiency virus (HIV)-positive blood donations by HIV-seronegative donors in a northern Thailand HIV epicenter.
    Sawanpanyalert P; Yanai H; Kitsuwannakul S; Nelson KE
    J Infect Dis; 1996 Oct; 174(4):870-3. PubMed ID: 8843233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.
    Ward JW; Holmberg SD; Allen JR; Cohn DL; Critchley SE; Kleinman SH; Lenes BA; Ravenholt O; Davis JR; Quinn MG
    N Engl J Med; 1988 Feb; 318(8):473-8. PubMed ID: 3422337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
    Ling AE; Robbins KE; Brown TM; Dunmire V; Thoe SY; Wong SY; Leo YS; Teo D; Gallarda J; Phelps B; Chamberland ME; Busch MP; Folks TM; Kalish ML
    JAMA; 2000 Jul; 284(2):210-4. PubMed ID: 10889595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand.
    Kitayaporn D; Bejrachandra S; Chongkolwatana V; Chandanayingyong D; Weniger BG
    Transfusion; 1994 Feb; 34(2):152-7. PubMed ID: 8310487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
    Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
    AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.
    Lackritz EM; Satten GA; Aberle-Grasse J; Dodd RY; Raimondi VP; Janssen RS; Lewis WF; Notari EP; Petersen LR
    N Engl J Med; 1995 Dec; 333(26):1721-5. PubMed ID: 7491134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group.
    Petersen LR; Doll LS
    Transfusion; 1991 Oct; 31(8):698-703. PubMed ID: 1926312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
    Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
    Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
    Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB
    Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV P24 antigen among HIV antibody seronegative blood donors in Osogbo Osun State, South Western Nigeria.
    Olowe OA; Mabayoje VO; Akanbi O; Adefioye OJ; Olowe RA; Fadeni EK; Oluremi AS; Opaleye OO
    Pathog Glob Health; 2016; 110(4-5):205-8. PubMed ID: 27386900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.
    Busch MP; Lee LL; Satten GA; Henrard DR; Farzadegan H; Nelson KE; Read S; Dodd RY; Petersen LR
    Transfusion; 1995 Feb; 35(2):91-7. PubMed ID: 7825218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of HIV by transfusion of HIV-screened blood: the value of a national register. The 'Recipients' Study Group of the French Society of Blood Transfusion.
    Courtois F; Jullien AM; Chenais F; Noel L; Pinon F
    Transfus Med; 1992 Mar; 2(1):51-5. PubMed ID: 1308463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of the confidential unit exclusion option.
    Petersen LR; Lackritz E; Lewis WF; Smith DS; Herrera G; Raimondi V; Aberle-Grasse J; Dodd RY
    Transfusion; 1994 Oct; 34(10):865-9. PubMed ID: 7940657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor.
    Phelps R; Robbins K; Liberti T; Machuca A; Leparc G; Chamberland M; Kalish M; Hewlett I; Folks T; Lee LM; McKenna M
    Transfusion; 2004 Jun; 44(6):929-33. PubMed ID: 15157262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.